India, April 1 -- Novo Nordisk AS has slashed prices of its blockbuster weight-loss drugs Ozempic and Wegovy in India, amid an onslaught of copycat drugs in the world's third most overweight population.

Ozempic's and Wegovy's lowest doses of 0.25 mg in India will now be priced at Rs.1,415 for a weekly shot from Rs.2,200 and Rs.2,712 earlier, respectively, the India unit of Denmark-based drugmaker said on Tuesday (31 March 2026). The new pricing, effective from 1 April, brings the monthly cost for the lowest doses of both drugs to Rs.5,660 from roughly Rs.10-12,000.

The markdown comes 11 days after the Indian patent for semaglutide-the active pharmaceutical ingredient (API) in the weight-loss drugs-expired in India. That opened the flood...